Screener
CareDx CDNA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by CareDx in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsNoncurrent.
The source filing: CareDx’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001217234-26-000033
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities, non-current | 10,901 | 24,165 |
| Intangible assets, net | 32,102 | 31,960 |
| Goodwill | 40,336 | 40,336 |
| Restricted cash | 551 | 551 |
| Other assets | 3,415 | 3,353 |
| Total assets | $411,062 | $413,228 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is CareDx's restricted cash?
- CareDx (CDNA) reported restricted cash of $551K in Q1 2026.
- How has CareDx's restricted cash changed year-over-year?
- CareDx's restricted cash increased by 0.2% year-over-year, from $550K to $551K.
- What is the long-term trend for CareDx's restricted cash?
- Over 5 years (2020 to 2025), CareDx's restricted cash has grown at a 15.3% compound annual growth rate (CAGR), from $270K to $551K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about CareDx's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude